We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
+20.59%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$6.25B
AUM Growth
+$1.16B
Cap. Flow
+$213M
Cap. Flow %
3.41%
Top 10 Hldgs %
36.07%
Holding
119
New
10
Increased
44
Reduced
39
Closed
7

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$82.3M
2
COST icon
Costco
COST
+$54.4M
3
MAR icon
Marriott International
MAR
+$39.2M
4
WY icon
Weyerhaeuser
WY
+$28.5M
5
BAP icon
Credicorp
BAP
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 15.8%
3 Consumer Discretionary 13.72%
4 Industrials 10.32%
5 Healthcare 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESS icon
76
Essex Property Trust
ESS
$18.3B
$7.16M 0.11%
31,250
-1,173
-4% -$281K
GLD icon
77
SPDR Gold Trust
GLD
$131B
$6.86M 0.11%
40,968
+2,100
+5% +$339K
MIDD icon
78
Middleby
MIDD
$6.05B
$6.79M 0.11%
86,000
WIX icon
79
WIX.com
WIX
$2.27B
$6.63M 0.11%
25,861
-4,130
-14% -$732K
IFF icon
80
International Flavors & Fragrances
IFF
$20.3B
$6.61M 0.11%
54,000
NEWR
81
DELISTED
New Relic, Inc.
NEWR
$6.56M 0.11%
95,248
+21,972
+30% +$1.31M
MOS icon
82
The Mosaic Company
MOS
$7.04B
$6.25M 0.1%
500,000
-120,000
-19% -$1.44M
PING
83
DELISTED
Ping Identity Holding Corp.
PING
$5.84M 0.09%
+181,954
New +$4.82M
DT icon
84
Dynatrace
DT
$12.8B
$5.62M 0.09%
+138,349
New +$4.55M
AGCO icon
85
AGCO
AGCO
$7.44B
$5.55M 0.09%
100,000
BYND icon
86
Beyond Meat
BYND
$302M
$5.36M 0.09%
+39,988
New +$4.73M
PS
87
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$5.19M 0.08%
287,564
+107,053
+59% +$1.81M
DLN icon
88
WisdomTree US LargeCap Dividend Fund
DLN
$6.26B
$5.1M 0.08%
109,744
-8,320
-7% -$374K
KRC icon
89
Kilroy Realty
KRC
$4.53B
$5.01M 0.08%
85,280
-33,052
-28% -$2M
BZUN
90
Baozun
BZUN
$167M
$4.93M 0.08%
128,182
+53,827
+72% +$1.69M
DOCU
91
DocuSign
DOCU
$10.4B
$4.82M 0.08%
27,999
-31,840
-53% -$4.01M
COP icon
92
ConocoPhillips
COP
$145B
$4.61M 0.07%
109,600
-111,917
-51% -$4.53M
FIVN icon
93
FIVE9
FIVN
$2.09B
$4.02M 0.06%
36,331
-23,479
-39% -$2.29M
PLAN
94
DELISTED
Anaplan, Inc.
PLAN
$4.01M 0.06%
+88,434
New +$3.7M
XLNX
95
DELISTED
Xilinx Inc
XLNX
$3.76M 0.06%
38,244
MDLA
96
DELISTED
Medallia, Inc.
MDLA
$3.73M 0.06%
+147,698
New +$3.53M
LQD icon
97
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.2B
$3.57M 0.06%
26,510
+1,703
+7% +$221K
DOC icon
98
Healthpeak Properties
DOC
$15.1B
$3.54M 0.06%
128,646
-54,114
-30% -$1.38M
WELL icon
99
Welltower
WELL
$170B
$2.87M 0.05%
55,405
-54,016
-49% -$2.65M
FMX icon
100
Fomento Económico Mexicano
FMX
$43.3B
$2.71M 0.04%
43,735
-331,154
-88% -$21.1M

Similar funds

Sarasin & Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Sarasin & Partners held 119 positions worth $6.25B, up 23% from $5.09B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sarasin & Partners deployed $213M of net new capital in Q2 2020, opening 10 new positions and adding to 44 existing holdings. Its largest new stake was Otis Worldwide: 2,220,859 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $82.3M trimmed.

  • Sarasin & Partners's largest Q2 2020 buy was Otis Worldwide: 2,220,859 shares worth $126M.
  • Sarasin & Partners added most to Merck in Q2 2020, an estimated $118M increase.
  • Sarasin & Partners's biggest Q2 2020 reduction was Pfizer, cutting an estimated $82.3M.
  • Sarasin & Partners fully exited Digital Realty Trust in Q2 2020, selling an estimated $5.78M.
  • Sarasin & Partners's ten largest holdings make up 36% of its $6.25B portfolio in Q2 2020.
  • Sarasin & Partners opened 10 new positions and closed 7 in Q2 2020.
  • Sarasin & Partners's portfolio value rose 23% quarter-over-quarter to $6.25B.

Based on Sarasin & Partners's 13F filing for Q2 2020, filed 17 Jul 2020.